Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Boehringer Ingelheim
Merck
Harvard Business School
Colorcon

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Vinflunine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Vinflunine: Patents, clinical trial progress, indications

Vinflunine is an investigational drug.

There have been 33 clinical trials for Vinflunine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2009.

The most common disease conditions in clinical trials are Carcinoma, Transitional Cell, Carcinoma, and Urinary Bladder Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, Pierre Fabre Medicament, and SCRI Development Innovations, LLC.

Recent Clinical Trials for Vinflunine
TitleSponsorPhase
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)Apices Soluciones S.L.Phase 1/Phase 2
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)IpsenPhase 1/Phase 2
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)Tesaro, Inc.Phase 1/Phase 2

See all Vinflunine clinical trials

Clinical Trial Summary for Vinflunine

Top disease conditions for Vinflunine
Top clinical trial sponsors for Vinflunine

See all Vinflunine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Harvard Business School
Express Scripts
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.